Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2025 Feb 8;317(1):379.
doi: 10.1007/s00403-025-03872-1.

Efficacy of formulations for treating hyperpigmentation: a systematic review and meta-analysis

Affiliations
Meta-Analysis

Efficacy of formulations for treating hyperpigmentation: a systematic review and meta-analysis

Barkha Kumari et al. Arch Dermatol Res. .

Abstract

Hyperpigmentation is a commonly occurring skin problem, it affects people's quality of life by causing anxiety and depression in them. This systematic review aims to critically evaluate the evidence of the effectiveness of formulations utilized in clinical trials for treating hyperpigmentation (melasma and photoaging). A comprehensive search was conducted using the Scopus, PubMed, Google Scholar, and National Center for Biotechnology Information (NCBI) databases, encompassing literature available up to December 2023. Clinical trials employing various formulations to address skin hyperpigmentation effectively were included and subsequently analysed. Meta-analysis was conducted using IBM SPSS Statistics software (version 29.0.1.0 for window) guidelines. From 102 literatures, 07 clinical studies that follow the inclusion criteria were selected. A total of 337 participants underwent a clinical trial, where 198 participants received the drug and 153 received a placebo. Meta-analysis of 07 clinical studies indicated that employed formulations have a significant effect on treating skin hyperpigmentation {Odds Ratio (OR): 4.260, 95% Confidence Interval (CI) 2.244 to 8.087, Probability value (P) p < 0.001} than placebo. Across 07 clinical trials, heterogeneity was found to be low {Tau-Squared (µ2) = 0.46, Degree of Freedom (df) = 6, p = 0.001, i-Squared (I2) = 0.76}. Formulations assessed in the meta-analysis are Ziziphus jujuba (Z. jujuba) syrup, Amorphophallus konjac (A. konjac) capsules, herbal mixture cream, cysteamine cream, 4-hexyl-1,3-phenylenediol lotion, lignin peroxidase cream, and 0.1% tretinoin cream. 0.1% tretinoin cream shows the lowest effect size while A. konjac capsules show the highest effect size among all the included studies. Formulations used in clinical trials have proven to be effective and safe for controlling skin hyperpigmentation compared to placebo treatments. Among all the formulations, 0.1% tretinoin demonstrates lower efficacy, while A. konjac exhibits the highest efficacy in treating hyperpigmentation. This systematic review will guide researchers and dermatologists in selecting quality products from the available formulations.

Keywords: Formulations; Hyperpigmentation; Melanin; Meta-analysis; Tyrosinase enzyme.

PubMed Disclaimer

Conflict of interest statement

Declarations. Competing interests: The authors declare no competing interests.

References

    1. Lall N, Kishore N (2014) Are plants used for skin care in South Africa fully explored? J Ethnopharmacol 153(1):61–84 - DOI - PubMed
    1. Parra EJ (2007) Human pigmentation variation: evolution, genetic basis, and implications for public health. Am J Phys Anthropology: Official Publication Am Association Phys Anthropologists 134(S45):85–105 - DOI
    1. Wang KH, Lin RD, Hsu FL, Huang YH, Chang HC, Huang CY, Lee MH (2006) Cosmetic applications of selected traditional Chinese herbal medicines. J Ethnopharmacol 106(3):353–359 - DOI - PubMed
    1. Lee SY, Baek N, Nam TG (2016) Natural, semisynthetic and synthetic tyrosinase inhibitors. J Enzyme Inhib Med Chem 31(1):1–3 - DOI - PubMed
    1. Obaid RJ, Mughal EU, Naeem N, Sadiq A, Alsantali RI, Jassas RS, Moussa Z, Ahmed SA (2021) Natural and synthetic flavonoid derivatives as new potential tyrosinase inhibitors: a systematic review. RSC Adv 11(36):22159–22198 - DOI - PubMed - PMC

Substances

LinkOut - more resources